Back to News
Market Impact: 0.35

Honeywell vs. 3M: Which Industrial Conglomerate Stock Should You Bet On?

HONMMMNDAQ
Company FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst EstimatesCapital Returns (Dividends / Buybacks)Legal & LitigationTransportation & LogisticsConsumer Demand & Retail
Honeywell vs. 3M: Which Industrial Conglomerate Stock Should You Bet On?

Honeywell (HON) and 3M (MMM), both diversified industrials, present contrasting outlooks for 2025. Honeywell anticipates 4-5% organic revenue growth, driven by robust performance in commercial aviation aftermarket, defense, and building automation, despite some weakness in industrial automation and increased debt. In contrast, 3M, while seeing strength in its Safety and Industrial and Transportation segments, faces significant headwinds from soft consumer retail demand and substantial ongoing litigation costs related to earplug lawsuits, despite projecting 2% adjusted organic sales growth. Ultimately, Honeywell is positioned as the stronger choice due to its diversified portfolio and more favorable sales and profit growth prospects, despite both stocks holding a Zacks #3 (Hold) rating.

Analysis

A comparative analysis of Honeywell (HON) and 3M (MMM) reveals divergent fundamental outlooks for 2025. Honeywell demonstrates robust momentum, with its commercial aviation aftermarket and defense & space businesses posting year-over-year sales growth of 7% and 13% respectively in the second quarter. This strength, coupled with an 8% organic sales increase in its Building Automation segment, underpins its full-year organic revenue growth guidance of 4-5%. However, this positive outlook is tempered by a 5% sales decline in its Industrial Automation segment and a notable increase in long-term debt to $30.2 billion. In contrast, 3M's performance is more mixed. While its Safety and Industrial segment saw organic sales improve 2.5% in the first half of 2025, the company faces significant headwinds from weak consumer retail demand and softness in the automotive OEM market, leading to a modest full-year adjusted organic sales growth forecast of 2%. More critically, 3M's outlook is clouded by substantial litigation risk and associated costs. Despite 3M's stock outperforming Honeywell's over the past six months (+6.4% vs +3.4%) and its forward P/E of 18.89X being below HON's 19.61X, consensus estimates project a stark difference in top-line performance: a 5.7% sales increase for HON versus an 8.8% decline for MMM.